(Q46868463)

English

A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer

scientific article published on 3 December 2007

Statements

A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit